Methylmercury (MeHg) is a potent developmental neurotoxicant that induces an oxidative stress response in the brain. It has been demonstrated that MeHg exposure increases nuclear factor erythroid 2-related factor 2 (Nrf2) activity. Nrf2 is a transcription factor that translocates to the nucleus in response to oxidative stress, and upregulates phase II detoxifying enzymes. Although, Nrf2 activity is augmented subsequent to MeHg exposure, it has yet to be established whether Nrf2 moves into the nucleus as a result. Furthermore, the potential effect MeHg might have on the non-receptor tyrosine kinase, Fyn, has not been addressed. Fyn phosphorylates Nrf2 in the nucleus, resulting in its inactivation, and consequent downregulation of the oxidative stress response. Here, we observe Nrf2 translocates to the nucleus subsequent to MeHg-induced oxidative stress. This response is concomitant with reduced Fyn expression and nuclear localization. Moreover, we detected an increase in phosphorylated Akt and glycogen synthase kinase 3 beta (GSK-3b) at activating and inhibitory sites, respectively. Akt phosphorylates and inhibits GSK-3b, which subsequently prevents Fyn phosphorylation to signal nuclear import. Our results demonstrate MeHg downregulates Fyn to maintain Nrf2 activity, and further illuminate a potential mechanism by which MeHg elicits neurotoxicity.
Introduction
Methylmercury (MeHg) is an established developmental neurotoxicant. It is particularly detrimental to the nervous system consequent to high-dose in utero exposure (Bakir et al., 1973; Harada, 1995) . It remains unclear, however, at what threshold concentration MeHg becomes developmentally neurotoxic. Furthermore, epidemiological studies have been inconclusive about the developmental impact of gestational MeHg exposure in populations, which consume fish, the primary exposure route in humans, as a dietary staple (Davidson et al., 2008 (Davidson et al., , 2011 Debes et al., 2006; Grandjean et al., 1997) . Reports in animal models document increased brain mercury (Hg) concentration in neonates exposed in utero (Newland and Reile, 1999) . Moreover, enhanced Hg deposition in cortical astrocytes has been observed (Charleston et al., 1995) . Despite extensive research, however, the mechanism (s) by which MeHg elicits neurotoxicity are not fully elucidated.
It is well known MeHg induces oxidative stress in the brain. Exposure enhances reactive oxygen species (ROS) generation (Shanker et al., 2004) and lipid peroxidation (Yin et al., 2007) . Furthermore, MeHg inhibits glutathione peroxidase (Franco et al., 2009) , an enzyme involved in ROS detoxification. Nonetheless, a direct correlation between oxidative stress induction and resultant toxicity is ambiguous. Nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription factor, has potential to clarify this connection. Nrf2 translocates to the nucleus in response to oxidative stress, and promotes transcription of phase II detoxifying enzymes (Itoh et al., 1997) . It has been demonstrated that MeHg increases total Nrf2 protein and upregulates antioxidant gene transcription . Although Nrf2 activity is enhanced subsequent to MeHg exposure, it has yet to be determined whether Nrf2 translocates to the nucleus as a consequence.
Additionally, the potential impact MeHg exposure has on the Src family kinase, Fyn, has not been explored. Nrf2 activation of phase II detoxifying enzyme transcription requires Fyn nuclear export (Kaspar and Jaiswal, 2011) . Moreover, Fyn phosphorylates Nrf2, signaling Nrf2 nuclear export, and subsequent downregulation of the oxidative stress response (Jain and Jaiswal, 2006) . Thus, the dynamic between Fyn and Nrf2 could provide vital insight into the mechanism of MeHg toxicity. It has been demonstrated that glycogen synthase kinase 3 beta (GSK-3b) phosphorylates Fyn, to signal nuclear import (Jain and Jaiswal, 2007) . However, GSK-3b and the signaling pathway, which regulates its activity, have not been examined consequent to MeHg exposure. Akt inactivates GSK-3b (Cross et al., 1995) . Furthermore, it was previously shown that phosphoinositide 3-kinase (PI3K) inhibition reduces Nrf2 activity (Wang et al., 2009a) . PI3K stimulates Akt activation (Franke et al., 1995) . Therefore, we hypothesized MeHg downregulates Fyn via Akt/GSK-3b signaling, in order to sustain Nrf2 activation.
In the present study, we assessed Nrf2 subcellular localization subsequent to MeHg exposure at a time (6 h) and concentration (5 mM), which elicit maximal Nrf2 activation in primary cortical astrocytes. Furthermore, we examined Fyn expression and localization, as well as the signaling pathway, which precedes its nuclear import. Our results suggest MeHg downregulates Fyn as to maintain Nrf2 activity.
Materials and methods

Cell culture
Primary astrocytes were isolated from postnatal day 1 SpragueDawley rats as previously described (Allen et al., 2001) . Briefly cortices were separated, meninges removed, and dissociated with dispase. Cells were plated at 10,000 cells/cm 2 on poly-L-lysine coated dishes, and maintained in minimum essential medium (MEM) supplemented with 10% horse serum. After 1-2 weeks in culture, astrocytes were used for respective experiments.
Chemicals
Methylmercury chloride (MeHg) was purchased from SigmaAldrich (St. Louis, MO). Stock solutions were made in water (biotech grade) (Fisher) and stored at À20 C. For all experiments, stocks were diluted to a final concentration (5 mM) in MEM without phenol red supplemented with 1% horse serum. 5 mM
MeHg was the lowest concentration at which a significant decrease in cell viability was observed (data not shown).
MTT assay
Cell viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) cleavage. MTT was purchased from Thermo Scientific (Rockford, IL), a stock solution made in Hank's Balanced Salt Solution (HBSS), and stored at 4 C. Briefly, astrocytes cultured in 96-well plates were exposed to MeHg for 6 h, treatment was removed, and cells were incubated with MTT. MTT was solubilized in dimethyl sulfoxide (DMSO) and absorbance measured at 570 nm. Background absorbance (690 nm) was subtracted from results.
LDH assay
Cytotoxicity was measured by lactate dehydrogenase (LDH) release using the Pierce LDH Cytotoxicity Assay Kit (Thermo Scientific) according to manufacture instructions. Briefly, astrocytes cultured in 96-well plates were exposed to MeHg for 6 h, supernatant transferred to a new plate, and incubated with reaction mixture. LDH absorbance was measured at 490 nm. Background absorbance (690 nm) was subtracted from results.
ROS generation
Reactive oxygen species (ROS) generation was assessed by CM-H2DCFDA (Invitrogen) fluorescence according to manufacture instructions. Briefly, astrocytes cultured in 96-well plates were pre-incubated with 5 mM CM-H2DCFDA for 20 min at 37 C, CM-H2DCFDA removed, and exposed to MeHg for 6 h. Fluorescence was measured at 520 nm (excitation at 485 nm).
Quantitative real-time PCR
Total RNA was purified from astrocytes cultured in 60 mm dishes with the RNeasy 1 Mini Kit (Qiagen), then reverse transcribed to cDNA with the High Capacity cDNA Reverse Transcription Kit (Thermo Scientific). Heme-oxygenase 1 (Hmox1), NAD(P)H quinone dehydrogenase 1 (Nqo1), and Fyn mRNA expression were measured by quantitative real-time PCR (qRT-PCR) using TaqMan 1 Gene Expression Assay probes (Thermo Scientific). The comparative 2 ÀDDCt method (Livak and Schmittgen, 2001 ) was used to determine fold difference, and normalized to glyceraldehyde 3-phosphate dehydrogenase (Gapdh). The following probes were used: Hmox1 (Assay ID: Rn00561387_m1), Nqo1 (Assay ID: Rn00566528_m1), Fyn (Assay ID: Rn00562616_m1), and Gapdh (Assay ID: Rn01775763_g1).
Immunocytochemistry
Astrocytes cultured on glass coverslips were fixed (4% paraformaldehyde), permeabilized (0.1% Triton), and blocked (5% bovine serum albumin). Cells were incubated overnight with rabbit anti-Nrf2 (1:50) (Santa Cruz). Secondary antibody was Alexa Fluor 1 488 goat-anti rabbit (1:500) (Thermo Scientific). Coverslips were mounted with ProLong TM Gold antifade reagent with DAPI.
Microscopy and analysis
An Inverted Olympus IX81 Widefield Microscope (20Â objective, NA = 0.40 Air, no boost) and Sensicam QE cooled CCD camera were used to capture fluorescent images. An image of a single area of interest was acquired in two fluorescent channels, Alexa 488 and DAPI, displayed, and measured in Volocity TM (Perkin Elmer Inc.). A protocol was established to measure the overlap of Nrf2 (stained with Alexa 488) and the nucleus of the cell (stained with DAPI). Briefly, cell nuclei were identified in the DAPI channel using average area to distinguish individual cells. The total cell area was then determined in the Alexa 488 channel. The intersect of Alexa 488 with DAPI was used to quantify Nrf2 nuclear intensity. Intensity is the average Nrf2 fluorescence as measured in pixels for a single cell. The mean intensity was used to compare untreated to treated. For each condition the identical protocol was applied.
Subcellular fractionation
Cytoplasmic and nuclear fractions were isolated with NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Scientific) according to manufacture instructions. Briefly, astrocytes cultured in 100 mm dishes were detached with phosphate buffered saline (PBS) plus protease inhibitor cocktail (Sigma), and cytoplasmic and nuclear fractions separated. Fractions were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and analyzed by western blot. Primary antibodies for rabbit antiNrf2 (1:1000) and rabbit anti-Fyn (1:1000) were purchased from Cell Signaling Technology (CST) (Danvers, MA). Mouse anti-a tubulin (CST) and rabbit anti-histone H3 (abcam) were used as cytosolic and nuclear loading controls, respectively. Secondary antibodies were goat anti-rabbit HRP and goat anti-mouse HRP (Thermo Scientific).
Whole-cell protein extraction
Astrocytes cultured in 60 mm dishes were lysed with RIPA Buffer (Sigma) plus protease inhibitor cocktail to obtain whole-cell lysates. Lysates were subjected to SDS-PAGE, and analyzed by western blot. Primary antibodies for p-Akt (Thr308), Akt, p-GSK-3b (Ser9), and GSK-3b (1:1000) were purchased from CST; Sp1 was purchased from abcam. Mouse anti-b actin (Sigma) was used as loading control. Secondary antibodies were goat anti-rabbit HRP and goat anti-mouse HRP (Thermo Scientific).
Densitometry
ImageJ was used to quantify western blots from subcellular fractions and whole-cell lysates. Cytosolic fractions, nuclear fractions, and whole-cell lysates were normalized to a-tubulin, histone H3, and b-actin, respectively.
Statistical analysis
All data are reported as mean AE standard error of the mean (SEM). Differences between treatments were analyzed by one-way analysis of variance (ANOVA), followed by Tukey's HSD post-hoc test using RStudio 1 . Statistical significance was set at p < 0.05.
Results
Astrocytes are vulnerable to MeHg-induced toxicity
Cell viability and cytotoxicity were determined by MTT and LDH assays, respectively. MTT assesses the number of live cells as a function of mitochondrial activity. We observed a significant decrease in cell viability (76.7 AE 6.7, p < 0.05; n = 3) as a result of MeHg exposure compared to untreated controls (Fig. 1A) . LDH measures cell membrane integrity as a function of extracellular LDH release. We observed a significant increase in cytotoxicity (127.2 AE 3.9, p < 0.001; n = 4) as a result of MeHg exposure compared to untreated controls (Fig. 1B) .
Methylmercury induces oxidative stress and Nrf2 activation
Oxidative stress was determined by CM-H2DCFDA fluorescence. CM-H2DCFDA is cleaved in the presence of oxidants, and creates a fluorescent by-product. We observed a significant increase in ROS generation (134.9 AE 3.0, p < 0.001; n = 4) as a result of MeHg exposure compared to untreated controls (Fig. 1C) . Nrf2 transcriptional targets Hmox1 and Nqo1 were measured by qRT-PCR. We observed a significant increase in Hmox1 (108.6 AE 13.6, p < 0.001; n = 5) and Nqo1 (3.68 AE 0.4, p < 0.001; n = 6) expression as a result of MeHg exposure compared to untreated controls (Fig. 1D). 3.3. Nrf2 translocates to the nucleus in response to methylmercury exposure Nrf2 localization was assessed by immunocytochemistry and subcellular fractionation. Immunostained astrocytes exhibited ubiquitous Nrf2 expression ( Fig. 2A) . We observed a significant increase in Nrf2 in cell nuclei (1.47 AE 0.08, p < 0.01; n = 4) as a result of MeHg exposure compared to untreated controls ( Fig. 2A and B) . We also detected a significant increase in Nrf2 in nuclear fractions (1.58 AE 0.10, p < 0.01; n = 3) as a result of MeHg exposure compared to untreated controls ( Fig. 2C and D) . However, there was no discernable change in Nrf2 in cytosolic fractions (0.97 AE 0.05, p = 0.7; n = 3) ( Fig. 2C and E) . MeHg for 6 h, and cell viability (A; n = 3) and cytotoxicity (B; n = 4) assessed by MTT and LDH assays, respectively. ROS generation (C; n = 4) was also measured by CM-H2DCFDA fluorescence, to indicate oxidative stress. Further, Nrf2 activation was confirmed by qRT-PCR of target genes Hmox1 (n = 5) and Nqo1 (n = 6) (D). All data were normalized to untreated controls, and represent the mean AE SEM. *p < 0.05, ***p < 0.001.
Methylmercury exposure downregulates Fyn
Fyn gene expression was analyzed by qRT-PCR. We observed a significant decrease (0.64 AE 0.07, p < 0.001; n = 6) as a result of MeHg exposure compared to untreated controls (Fig. 3A) . Additionally, specificity protein 1 (Sp1), the transcription factor, which controls Fyn expression (Gao et al., 2009) , was assessed by wholecell western blot. We observed a significant decrease (0.56 AE 0.07, p < 0.01; n = 3) as a result of MeHg exposure compared to untreated controls ( Fig. 3B and C) . Fyn localization was also examined by subcellular fractionation. We detected a significant decrease in Fyn in nuclear fractions (0.62 AE 0.02, p < 0.001; n = 3) as a result of Fig. 2 . Nrf2 translocates to the nucleus in response to MeHg exposure. Astrocytes were treated with 5 mM MeHg for 6 h, and immunostained for Nrf2 (A). Nrf2 mean intensity in cell nuclei was quantified from four distinct images (B; n = 4). Further, Nrf2 protein level was measured in nuclear (C, D; n = 3) and cytosolic fractions (C, E; n = 3) separated by subcellular fractionation. Representative blots for nuclear and cytosolic Nrf2, histone H3, and a-tubulin are displayed (C). Nuclear and cytosolic fractions were normalized to histone H3 and a-tubulin, respectively. All data were normalized to untreated controls, and represent the mean AE SEM. **p < 0.01, scale bar = 60 mm. Further, Fyn protein level was quantified in nuclear (D, E; n = 3) and cytosolic fractions (D, F; n = 3) separated by subcellular fractionation. Representative blots for nuclear and cytosolic Fyn, histone H3, and a-tubulin are displayed (D). Nuclear and cytosolic fractions were normalized to histone H3 and a-tubulin, respectively. All data were normalized to untreated controls, and represent the mean AE SEM. **p < 0.01, ***p < 0.001.
MeHg exposure compared to untreated controls ( Fig. 3D and E) . However, there was no discernable change in Fyn in cytosolic fractions (1.09 AE 0.09, p = 0.4; n = 3) ( Fig. 3D and F) . Furthermore, we assessed the signaling cascade, which precedes Fyn nuclear import by whole-cell western blot. We observed a significant increase in p-Akt (2.25 AE 0.33, p < 0.05; n = 3) ( Fig. 4A and B ) and p-GSK-3b (1.63 AE 0.03, p < 0.001; n = 3) ( Fig. 4A and C) as a result of MeHg exposure compared to untreated controls. There was no discernable change in total Akt (0.99 AE 0.04, p = 0.7; n = 3) or GSK3b (1.00 AE 0.03, p = 1.0; n = 3) (Fig. 4C) .
Discussion
The pro-oxidative properties of MeHg have long been recognized (Fretham et al., 2012) . MeHg enhances ROS generation twofold: mitochondrial membrane potential decreases (Yin et al., 2007) , which results in spurious electron escape from the electron transfer chain, and glutathione peroxidase activity is reduced (Franco et al., 2009) , augmenting intracellular hydrogen peroxide (Shanker et al., 2004) . These effects induce oxidative stress, which in turn upregulates antioxidant enzyme defenses directed by Nrf2 (Wang et al., 2009a) . Nrf2 nuclear translocation is required to stimulate this response (Huang et al., 2000) . It has not been quantifiably demonstrated, however, that MeHg promotes Nrf2 nuclear localization. Here, we confirm Nrf2 translocates to the nucleus consequent to MeHg exposure both by immunocytochemistry and subcellular fractionation. Furthermore, at the MeHg concentration and time-point examined, downstream antioxidant enzyme expression increases. Kelch-like ECH-associated protein 1 (Keap1) was also assessed to corroborate Nrf2 activation. Keap1 binds Nrf2 and represses its activity (Itoh et al., 1999) . Moreover, it serves as an adaptor for ubiquitin ligases, which mark Nrf2 for proteasomal degradation (Kobayashi et al., 2004) . We observed MeHg reduces Keap1 expression and protein level [As shown in Supplementary Fig. S1 in the online version at DOI: 10.1016/j. neuro.2017.07.028].
To further elucidate the potential mechanism by which MeHg augments Nrf2 activity, we examined Fyn, a non-receptor tyrosine kinase, known to phosphorylate Nrf2 and signal its nuclear export (Jain and Jaiswal, 2006) . Fyn is also activated in response to oxidative stress (Abe and Berk 1999; Sanguinetti et al., 2003) . Moreover, MeHg has been observed to increase Fyn kinase activity in oligodendrocyte precursor cells (Li et al., 2007) . To our knowledge, however, a direct connection between Nrf2 and Fyn has not been examined consequent to MeHg exposure. Our study reveals, MeHg reduces Fyn transcription and Sp1, the transcription factor that regulates Fyn expression (Gao et al., 2009) , total protein. Interestingly, Nrf2 was found to bind Sp1, and repress its activity at Fig. 4 . MeHg exposure alters the Akt/GSK-3b signaling pathway, which regulates Fyn nuclear import. Astrocytes were treated with 5 mM MeHg for 6 h, and relevant protein levels assessed by whole-cell western blot. Representative blots for p-Akt(Thr308), Akt, p-GSK-3b(Ser9), GSK-3b, and b-actin are displayed (A). p-Akt (B; n = 3) and p-GSK-3b (C; n = 3) were normalized to total Akt and GSK-3b, respectively. All data were normalized to untreated controls, and represent the mean AE SEM. *p < 0.05, **p < 0.01. Blue arrows indicate the effects of MeHg, while red arrows designate processes disrupted subsequent to MeHg exposure. Abbreviations: MeHg (methylmercury); GSK-3b (glycogen synthase kinase 3 beta), ROS (reactive oxygen species); Nrf2 (nuclear factor erythroid 2-related factor 2); ARE (antioxidant response element); Hmox1 (heme oxygenase); Nqo1 (NAD(P)H quinone dehydrogenase); Sp1 (specificity protein 1). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) the Tgf-b1 promoter (Gao et al., 2014) . We did observe a significant decrease in Tgf-b1 transcription (As shown in Supplementary  Fig. S2 in the online version at DOI: 10.1016/j.neuro.2017.07.028), however, additional experiments would be necessary to confirm Nrf2 binds Sp1 at the MeHg concentration and time-point examined.
In addition, Sp1 was observed to interact with Nrf2, and promote Hmox1 transcription (Chi et al., 2015) . Intriguingly, Sp1 siRNA knockdown attenuated this response. Furthermore, this interaction was ROS-independent. Consequently, the detected Sp1 decrease reported herein could reveal a mechanism by which MeHg mitigates the antioxidant response apart from oxidative stress induction. We failed, however, to observe a concomitant decrease in Hmox1 expression. This potentially could be attributed to a compensatory mechanism. Several diverse signaling pathways regulate Hmox1 transcription (Kietzmann et al., 2003; Martin et al., 2004; Pronk et al., 2014) . p38 mitogen-activated protein kinase was previously demonstrated to induce Sp1-dependent Hmox1 activation (Lin et al., 2011) . Moreover, Nrf2 translocation and activation are negatively regulated by p38 (Huang et al., 2000; Yu et al., 2000) . Possibly, MeHg-induced Nrf2 activation downregulates p38/Sp1-dependent pathways, but this remains to be explored.
Nrf2 transcriptional activity requires Fyn nuclear export. Furthermore, the phosphorylation sites, which mediate this process are oxidant sensitive (Kaspar and Jaiswal, 2011) . It had yet to be investigated, however, whether MeHg has an effect on Fyn subcellular localization. Here, we observe a decrease in Fyn nuclear protein consequent to MeHg exposure. Interestingly, no change in Fyn cytosolic protein was detected. GSK-3b mediated Fyn phosphorylation is necessary for nuclear translocation (Jain and Jaiswal, 2007) . Moreover, this process is redox-sensitive. We detected an increase in GSK-3b serine 9 phosphorylation, subsequent to MeHg exposure. Akt phosphorylates GSK-3b at this site, inhibiting its activity (Cross et al., 1995) . This result is inconsistent with a previous report, which found MeHg enhanced GSK-3b activity (Fujimura and Usuki, 2015) . However, the MeHg concentration examined was considerably lower than that in our report. In addition, the former study was in neural progenitor cells, likely more sensitive to MeHg-induced toxicity. We did not observe any change in active GSK-3b (As shown in Supplementary Fig. S3 in the online version at DOI: 10.1016/j.neuro.2017.07.028). Other heavy metals have also been found to activate GSK-3b (DeFuria and Shea, 2007; Wang et al., 2009b) . However, it remains to be determined whether the concentration, time-point, and model system employed contribute to this differential result. PI3K/Akt have been shown to activate Fyn (Yadav and Denning, 2011) . However, this result was attributed to constitutively active Ras overexpression. To our knowledge, PI3K/Akt-induced Fyn activation has not been observed out of the oncogenic context. Interestingly, c-Src, another Src family non-receptor tyrosine kinase, was found to act upstream of PI3K/Akt in arachidonic acid (AA) stimulated Hmox1 transcription (Lin et al., 2017) . Furthermore, PI3K/Akt induced extracellular-signal related kinase (Erk1/ 2) activation, and subsequent Nrf2 nuclear translocation. MeHg has been observed to enhance AA release (Shanker et al., 2002) . Moreover, Erk1/2 phosphorylation increases at the same MeHg concentration and time-point as examined in the present study. Here, we detected an increase in Akt threonine 308 phosphorylation, consequent to MeHg exposure. Phosphoinositide-dependent kinase-1 [PDK1] phosphorylates Akt at this site, potentiating its activity (Alessi et al., 1997) . Our studies, for the first time, identify a plausible feedback loop, which sustains MeHginduced Nrf2 activation (Fig. 5) .
In summary, we have demonstrated MeHg-induces Nrf2 nuclear localization and subsequent upregulation of the phase II detoxifying enzyme response. Nrf2 activity is protracted by Fyn nuclear export, directed by Akt-stimulated GSK-3b inhibition. Furthermore, Sp1 regulated Fyn expression is reduced. Further studies, however, would be necessary to definitively determine how MeHg modulates this complex signaling cascade in order to elicit neurotoxicity over time.
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